MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2018 International Congress

    A detailed clinical study of pain in 1957 participants with Parkinson’s disease

    M. Silverdale, C. Kobylecki, L. Kass-Iliyya, P. Martinez-Martin, D. Grosset, M. Hu, M. Lawton, S. Cotterill, R. Chaudhuri, H. Morris, F. Baig, N. Williams, L. Hubbard (Manchester, United Kingdom)

    Objective: We performed a large clinical study to investigate potential factors contributing towards pain in Parkinson’s disease (PD). Background: The causes of pain in PD…
  • 2018 International Congress

    Motor and non-motor symptoms of a 7.5-year prospective study of patients with Parkinson’s disease

    A. Yoritaka, Y. Shimo, T. Hatano, N. Hattori (Saitama, Japan)

    Objective: Previously, we retrospectively reported the prevalence and risks of motor and non-motor symptoms of a large number of patients (1453) with Parkinson’s disease (PD)…
  • 2018 International Congress

    Odor identification in PD patients and controls in Estonian cohort

    I. Kalju, T. Toomsoo, K. Vender (Tallinn, Estonia)

    Objective: To evaluate odors that discriminate Parkinson patients from healthy persons. Background: More than 90% of PD patients are diagnosed with olfactory impairment. The investigation…
  • 2018 International Congress

    Progression of sleep disorders spectrum in Parkinson’s Disease: A 5 year clinical longitudinal study

    Objective: To investigate longitudinal changes in the prevalence of different sleep disorders in the PPMI cohort of patients with Parkinson’s Disease (PD). Background: Sleep disturbances…
  • 2018 International Congress

    Salivary Alpha-Synuclein and tau in Parkinson’s Disease and Progressive Supranuclear Palsy

    G. Vivacqua, A. Fabbrini, R. Mancinelli, D. Belvisi, G. Fabbrini, A. Suppa, A. Berardelli (Cambridge, United Kingdom)

    Objective: The aim of this study is to measure alpha-synuclein (a-syn) total, a-syn oligomers (a-syn olig) and total tau protein concentration in the saliva of…
  • « Previous Page
  • 1
  • …
  • 175
  • 176
  • 177

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • #24970 (not found)
  • Life expectancy with and without Parkinson’s disease in the general population
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • To be or not to bupropion: a drug-induced parkinsonism?
  • Effect of marijuana on Essential Tremor: A case report
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley